Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
35 studies found for:    " July 22, 2009":" August 21, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Unknown  Reducing HIV Risks in African American Teens
Condition: HIV Infections
Intervention: Behavioral: Healthy Futures parent education
22 Completed Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration
Conditions: HIV Infection;   HIV Infections
Intervention: Drug: maraviroc
23 Completed Evaluating the Pharmacokinetics of 400 mg Oral Dose of Raltegravir in HIV-Infected Pre-Menopausal Women
Condition: HIV Infections
Intervention:
24 Completed Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study)
Conditions: HIV;   Depression;   HIV Infections
Interventions: Behavioral: Cognitive behavioral therapy (CBT) for adherence and depression (CBT-AD);   Behavioral: Life-steps adherence treatment;   Behavioral: Information and supportive psychotherapy (ISP) for adherence and depression (ISP-AD)
25 Completed Raltegravir Switch for Toxicity or Adverse Events
Conditions: HIV/AIDS;   Antiretroviral Therapy;   HIV Infections
Interventions: Drug: tenofovir emtricitabine raltegravir;   Drug: Lamivudine Abacavir Raltegravir;   Drug: Abacavir free
26 Completed Safety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults.
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK2248761;   Drug: Lopinavir/ritonavir;   Drug: HAART;   Drug: Placebo
27 Unknown 
Has Results
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1349572;   Drug: efavirenz
28 Completed
Has Results
Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPS
Conditions: HIV Infections;   Pneumococcal Infections
Interventions: Biological: 13-valent pneumococcal conjugate vaccine;   Procedure: Blood draw
29 Completed
Has Results
Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in HIV-Infected Subjects 6 Years of Age or Older Who Are Naive to Pneumococcal Vaccine
Conditions: HIV Infections;   Pneumococcal Infections
Interventions: Biological: 13-valent Pneumococcal Conjugate Vaccine (13vPnC);   Biological: 23-valent Pneumococcal Polysaccharide Vaccine (23vPS);   Procedure: Blood draw
30 Unknown  Genotypic Resistant HIV Strains in Taiwan
Conditions: HIV-1;   HIV Infections
Intervention:
31 Completed
Has Results
A Pilot Study Assessing the Integrase Inhibitor GSK1349572 in HIV-infected Persons With Virus Resistant to Raltegravir
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1349572 (Cohort I);   Drug: GSK1349572 (Cohort II)
32 Completed Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load
Condition: HIV Infections
Intervention:
33 Completed Faster Identification of TB and Evaluation of Drug Resistance in HIV-infected People
Condition: HIV Infections
Intervention:
34 Completed
Has Results
Switch From Combivir or Trizivir to Truvada - Mitochondrial Effects
Condition: HIV
Interventions: Drug: Truvada;   Drug: Combivir;   Drug: Trizivir
35 Active, not recruiting Comparing Two Types of Swabs in Collecting Cell Samples for Anal Pap Tests and Human Papillomavirus Tests in Men Who Have Sex With Men
Conditions: Anal Cancer;   Nonneoplastic Condition;   Precancerous Condition
Intervention: Other: Papanicolaou test

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-35) Next Page   
Indicates status has not been verified in more than two years